AIC
RMD icon

Ameritas Investment Company’s ResMed RMD Stock Holding History

Ameritas Investment Company’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-80
Closed -$15.5K – 1791
2021
Q1 		$15.5K Buy
+80
New +$16K ﹤0.01% 1376
2020
Q2 		– Sell
-19
Closed -$3K – 1327
2020
Q1 		$3K Buy
+19
New +$3.03K ﹤0.01% 1515

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameritas Investment Company's RMD Position: Q2 2021 in Review

Ameritas Investment Company sold out of ResMed (RMD) in Q2 2021, closing a stake of 80 shares — an estimated $15.5K sold.

Ameritas Investment Company first reported a position in RMD in Q1 2020 and held it in 2 quarters. The position peaked at $15.5K in Q1 2021. 662 funds tracked by Wall St. Rank hold RMD as of Q2 2021.

  • Ameritas Investment Company reported no remaining ResMed position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 80 ResMed shares in Q2 2021, an estimated $15.5K.
  • Ameritas Investment Company first reported a position in ResMed in Q1 2020 and held it in 2 quarters.
  • Ameritas Investment Company's ResMed position peaked at $15.5K in Q1 2021.
  • 662 funds tracked by Wall St. Rank held ResMed as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.